197 filings
Page 4 of 10
EFFECT
3ma36scaelf z1kelhe
31 Dec 20
Notice of effectiveness
12:20am
CORRESP
zcwehwwc 96rj
30 Dec 20
Correspondence with SEC
12:00am
UPLOAD
cn4ra
29 Dec 20
Letter from SEC
12:00am
F-3
5l2 cg9vnc
23 Dec 20
Shelf registration (foreign)
4:14pm
6-K
g4rp84pnip9
10 Nov 20
Open Market Sale Agreementsm
8:21am
424B5
rm7hgnk7ji o2
10 Nov 20
Prospectus supplement for primary offering
8:14am
6-K
0hkfcdqzvd77o00hs4v
10 Nov 20
Current report (foreign)
6:33am
6-K
ski5m0 exy5
9 Nov 20
Affimed and Roivant Sciences Announce Licensing and Strategic
4:31pm
6-K
jbbr6ybt091gg4qym9g
11 Aug 20
Condensed Consolidated Financial Statements
6:32am
6-K
kr9m83nrtvhx
5 Aug 20
Current report (foreign)
7:00am
6-K
4hah2x 48a5eh8
27 Jul 20
Current report (foreign)
4:36pm
6-K
cf6 k2uhevklbqjaqhbf
10 Jul 20
Affimed Announces Annual General Meeting of Shareholders
8:11am
6-K
lvzotw6flhxxx xc9
23 Jun 20
Current report (foreign)
6:44am
6-K
eeklyk3 u67w
13 May 20
Open Market Sale Agreementsm
4:32pm
424B5
f1kl ahjo
13 May 20
Prospectus supplement for primary offering
4:31pm
6-K
vsqo0pkc5 0qlfcllkuc
28 Apr 20
Affimed Reports 2019 Financial Results and Recent Operational Progress
6:48am
6-K
4oamqly1y kcl7pkq
3 Feb 20
Current report (foreign)
7:38am
6-K
yn7oufnns4 als
19 Nov 19
Current report (foreign)
7:47am
6-K
v96i6t
13 Nov 19
Current report (foreign)
5:18pm